John Oertle

In this engaging conversation, Dr. John Oertle, the Chief Medical Director at Envita Medical Centers, discusses the revolutionary potential of personalized precision medicine for cancer treatment. He highlights the shift from one-size-fits-all therapies to individualized protocols tailored to genetic and environmental factors. The importance of teaching the immune system to recognize and attack tumors is a key focus, alongside insights on how biological age influences disease prevention. Discover how innovative therapies can significantly enhance patient outcomes and longevity.